Thomas Smith

Stock Analyst at Leerink Partners

(1.05)
# 3,504
Out of 4,758 analysts
70
Total ratings
29.03%
Success rate
n/a
Average return
Main Sectors:

Stocks Rated by Thomas Smith

Q32 Bio
Dec 11, 2024
Downgrades: Market Perform
Price Target: $68$9
Current: $2.33
Upside: +286.27%
Aclaris Therapeutics
Nov 19, 2024
Upgrades: Outperform
Price Target: $2$7
Current: $1.82
Upside: +284.62%
Alumis
Jul 23, 2024
Initiates: Outperform
Price Target: $29
Current: $5.10
Upside: +468.63%
Cartesian Therapeutics
Apr 23, 2024
Initiates: Outperform
Price Target: $39
Current: $17.85
Upside: +118.49%
Sagimet Biosciences
Mar 25, 2024
Initiates: Outperform
Price Target: $26
Current: $3.65
Upside: +612.33%
RAPT Therapeutics
Feb 21, 2024
Downgrades: Market Perform
Price Target: $10
Current: $1.12
Upside: +792.86%
ABIVAX Société Anonyme
Nov 14, 2023
Initiates: Outperform
Price Target: $20
Current: $8.29
Upside: +141.25%
argenx SE
Mar 3, 2023
Maintains: Outperform
Price Target: $430$435
Current: $613.18
Upside: -29.06%
Disc Medicine
Feb 28, 2023
Initiates: Outperform
Price Target: $36
Current: $55.50
Upside: -35.14%
Equillium
Feb 8, 2023
Maintains: Outperform
Price Target: $12$7
Current: $0.79
Upside: +786.08%
Maintains: Outperform
Price Target: $9$7
Current: $0.83
Upside: +743.37%
Maintains: Outperform
Price Target: $14$21
Current: $19.52
Upside: +7.58%
Maintains: Outperform
Price Target: $40$45
Current: $15.88
Upside: +183.38%
Initiates: Outperform
Price Target: $6
Current: $4.29
Upside: +39.86%
Maintains: Outperform
Price Target: $5$6
Current: $4.92
Upside: +21.95%
Downgrades: Market Perform
Price Target: $9$5
Current: $1.15
Upside: +334.78%
Initiates: Outperform
Price Target: $17
Current: $39.82
Upside: -57.31%
Maintains: Outperform
Price Target: $68$64
Current: $21.33
Upside: +200.05%
Maintains: Outperform
Price Target: $66$70
Current: $18.22
Upside: +284.19%
Maintains: Outperform
Price Target: $50$29
Current: $8.31
Upside: +248.98%
Maintains: Outperform
Price Target: $33$26
Current: $3.81
Upside: +582.41%
Maintains: Market Perform
Price Target: $13$12
Current: $0.25
Upside: +4,646.84%
Maintains: Outperform
Price Target: $18$12
Current: $28.68
Upside: -58.16%
Maintains: Outperform
Price Target: $15$10
Current: $3.39
Upside: +194.99%
Maintains: Outperform
Price Target: $675$400
Current: $4.14
Upside: +9,561.84%
Maintains: Outperform
Price Target: $42$80
Current: $11.93
Upside: +570.58%